Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
JOINN Laboratories (China) Co., Ltd. Class H ( (HK:6127) ) has issued an update.
JOINN Laboratories (China) Co., Ltd. has announced proposed amendments to its Articles of Association and the rules of procedures for its general meeting of shareholders. These changes are in response to the upcoming amendments to the Company Law of the People’s Republic of China, effective from July 1, 2024. The key amendments include altering the number of directors on the board and removing the supervisory committee, aligning with legal and regulatory updates. These changes are expected to impact the company’s governance structure and could influence its operational efficiency and compliance with new legal standards.
The most recent analyst rating on (HK:6127) stock is a Hold with a HK$16.30 price target. To see the full list of analyst forecasts on JOINN Laboratories (China) Co., Ltd. Class H stock, see the HK:6127 Stock Forecast page.
More about JOINN Laboratories (China) Co., Ltd. Class H
JOINN Laboratories (China) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. The company operates in the biotechnology and pharmaceutical industry, focusing on providing laboratory services and research support for drug development and testing.
Average Trading Volume: 6,769,040
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.27B
For an in-depth examination of 6127 stock, go to TipRanks’ Overview page.